Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Translational Genomics Research Institute (TGen) is a non-profit biomedical research institute dedicated to conducting groundbreaking research with various genetic components of common and complex diseases. Based in Phoenix, Arizona, TGen focuses on helping patients with neurological disorders, cancer, diabetes, and infectious diseases through the use of genomic sequencing and precision medicine. In 2016, TGen formed an affiliation with City of Hope, creating a powerhouse in precision medicine to accelerate the speed at which biological insights are converted into clinical therapies. The institute operates several specialized centers, including the Pathogen Genomics Division and the Center for Rare Childhood Disorders. TGen's research model emphasizes collaborative partnerships with clinical providers to bring precision medicine directly to the patient's bedside.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TGen Foundation.